Joshua D. Lenchus, DO, RPh, FACP, FHM, discusses the lack of impact comparative effectiveness research (CER) has had on patient safety. In addition, he speaks about the need for more comparisons that study safety and efficacy in patient populations.
Joshua D. Lenchus, DO, RPh, FACP, FHM, discusses the lack of impact comparative effectiveness research (CER) has had on patient safety. In addition, he speaks about the need for more comparisons that study safety and efficacy in patient populations. There are asymmetries which need to be overcome in the delivery of information between industry and government.
Dr. Lenchus believes regulations on industry need to be loosened and must be on par with the regulations that will guide the government’s interactions with CER.
Balancing Life and Myeloma: A Patient-Centered Approach
November 22nd 2024In this second part of our discussion with Don M. Benson, MD, PhD, from our recent Institute for Value-Based Medicine® event in Cleveland, Ohio, he explains how his ultimate goal for his patients is for them to live as long and as well as possible.
Read More
Community Investment, Engagement Are Essential to Fully Address Cardiovascular Health Disparities
November 19th 2024Community-based researchers can teach clinicians a lot about how to best approach underserved populations disproportionately impacted by cardiovascular health complications.
Read More